Takeda Pharmaceutical Company Limited Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Takeda Pharmaceutical Company Limited (TKPHF) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of -JPY 153.34 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2025-06-25
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month as first filed |
|---|---|---|
| 2025-03-31 | -153.34B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 968.84B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 618.77B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 583.97B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 309.30B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | -207.07B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 30.98B JPY 20-F · filed 2021-06-29 | 34.64B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 46.61B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | -51.82B JPY 20-F · filed 2019-06-27 |